H & H Remedies Recalls White Liniment Due to CGMP Deviations
H & H Remedies, LLC is voluntarily recalling 365 bottles of White Liniment due to Current Good Manufacturing Practice (CGMP) deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the agency classification as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe).
Plain-English summary
H & H Remedies, LLC is voluntarily recalling 365 bottles of White Liniment. The product is packaged in 1 oz, 4 oz, and 6 oz bottles and was manufactured and sold by H & H Remedies, LLC, located in New Philadelphia, Ohio. The recall covers lot numbers H20-01W through H20-84W.
The recall was initiated because of Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this recall as Class II, which indicates a situation that may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
The product was distributed nationwide in the United States. Consumers who have this product should stop using it and contact the recalling firm for instructions on how to return or dispose of the product.
The recalled product
- Product
- White Liniment packaged in a) 1 oz; b) 4 oz.; and c) 6 oz bottles. Mfg & Sold by: H & H Remedies, LLC c/o David A. Cox, 1219 South Broadway, New Philadelphia, OH 44663
- Manufacturer
- H & H Remedies, LLC
- Category
- Drug — Topical Medication
- Hazard
- Affected units
- 365
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: H20-01W thru H20-84W
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by H & H Remedies, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · H & H Remedies, LLC
See all →- ModerateH & H Remedies Recalls Vapor Ointment Due to Manufacturing Deviations
FDA (Drugs) · 2020-11-18
- ModerateH & H Remedies Recalls Union Salve Due to CGMP Deviations
FDA (Drugs) · 2020-11-18
Same hazard · cgmp deviations
See all →- SevereBaxter Recalls Famotidine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Pantoprazole Sodium Infusion Bags Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Nexterone Amiodarone Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- HighWashington Homeopathic Products Recalls Silicea 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- HighDiphenhydramine HCl Oral Solution Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2022-09-14
- HighDiphenhydramine Solution Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- ModerateFDA Recalls Hand Sanitizer Gel Due to Manufacturing Deviations
FDA (Drugs) · 2020-09-02
- ModerateFDA Recalls Acetaminophen and Codeine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2020-04-22